Ann: MedAdvisor to launch in Asia with Zuellig Pharma, page-4

  1. 4,217 Posts.
    lightbulb Created with Sketch. 238
    Looks like the relationship with EBOS is benefiting both parties.

    Symbion (which EBOS acquired in 2013) is 40% owned by Zuellig.

    MedAdvisors tentacles are growing.

    2019 should be a cracker with opportunities now across 3 continents.

    And all 3 being multiples in size to Australia.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $50.02M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $44.53K 558.3K

Buyers (Bids)

No. Vol. Price($)
1 12658 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 84920 2
View Market Depth
Last trade - 14.07pm 25/07/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.